Improving equitable access to genomics-based clinical trials remains a critical priority in cancer care, according to Dr.

Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient access. The high closure rate of trial sites reflects unique research objectives ...

In a time when COAs are more nuanced, critical and complex than ever, researchers can turn to best practices to move forward ...

Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...

Together, the panelists discussed the multifaceted challenges that rural communities face in accessing clinical trials and offered actionable strategies to overcome these barriers. Breaking Down ...

A cancer diagnosis presents patients with complex treatment decisions. While traditional therapies like surgery, chemotherapy, and radiation remain standard options, clinical trials offer additional ...

Among the many catchphrases of the Affordable Care Act individual mandates, pre-existing conditions clinical trials is one that has flown under the radar. But in terms of immediate impact, it is one ...

Forbes contributors publish independent expert analyses and insights. Tor Constantino is an ex-reporter, turned AI consultant & tech writer. Parexel's research found 6% of surveyed executives say ...

Blinatumomab combined with chemotherapy increased disease-free survival by 61% in children with B-cell acute lymphoblastic leukemia. Hispanic children, who often face worse outcomes, saw a 71% ...

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. The first ...